Bacterial infections caused by 'superbugs' are increasing globally, and conventional
antibiotics are becoming less effective against these bacteria, such that we risk entering a …

Antimicrobial resistance (AMR) is one of the greatest threats to human health that, by 2050,
will lead to more deaths from bacterial infections than cancer. New antimicrobial agents …

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) continue to
endanger public health. Here, we report the synthesis of neolignan isomagnolone (I) and its …

In the past few decades, peptide antibacterial products with unique antibacterial
mechanisms have attracted widespread interest. They can effectively reduce the probability …

Clinical treatment of pathogenic infection has emerged as a growing challenge in global
public health. Such treatment is currently limited to antibiotics, but abuse of antibiotics have …

There has been a dramatic increase in the emergence of antibiotic‐resistant bacterial
strains, which has made antibiotic choices for infection control increasingly limited and more …

Maleimide chemistry stands out in the bioconjugation toolbox by virtue of its synthetic
accessibility, excellent reactivity, and practicability. The second‐generation of clinically …

Multiple enzyme‐driven biological catalytic cascades occur in living organisms, guiding
highly efficient and selective transformations of substrates. Inspired by the merits of these …

Finding strategies against the development of antibiotic resistance is a major global
challenge for the life sciences community and for public health. The past decades have seen …

We present the use of functionalized gold nanoparticles (AuNPs) to combat multi-drug-
resistant pathogenic bacteria. Tuning of the functional groups on the nanoparticle surface …